Mental Health Centre Glostrup, Copenhagen University Hospital, Denmark.
Department of Clinical Medicine, Aalborg University, Denmark; Department of Psychiatry, Aalborg University Hospital, Denmark; Department of Clinical Epidemiology, Aalborg University Hospital, Denmark.
J Sci Med Sport. 2018 Mar;21(3):286-290. doi: 10.1016/j.jsams.2017.06.018. Epub 2017 Jul 4.
Soluble urokinase-type plasminogen activator receptor (suPAR) is a novel inflammatory marker, associated with lifestyle diseases and mortality risk. No studies have investigated whether physical activity may reduce suPAR levels using a randomized controlled design.
suPAR and C-reactive protein (CRP) levels were determined in blood samples from a previous randomized controlled trial with Pakistani immigrants in Norway, 2008. The study included physically inactive men that were randomized to an intervention group (supervised group exercises) or a control group and followed for 5 months. A linear regression model was used and adjusted for age, inactivity level at baseline, and mean difference in CRP levels.
Overall, 80 and 53 participants were included in the intervention and control group, respectively. Obesity and smoking were associated with higher suPAR levels at baseline. The intervention group had a mean suPAR level of 2.65 (95% CI=2.48-2.78)ng/mL at baseline compared to 2.80 (95% CI=2.65-2.95)ng/mL at post-test, and thereby significantly increased suPAR levels after intervention (p=0.02). In the control group, mean suPAR level significantly increased from 2.93 (95% CI=2.68-3.16)ng/mL at baseline to 3.09 (95% CI=2.81-3.38)ng/mL at post-test (p=0.04). When comparing change from baseline to post-test in suPAR levels for the intervention group versus the control group, no significant change in the unadjusted model was found (β=-0.002, 95% CI=-0.219-0.215). Similar results were found for CRP levels.
There was no change in suPAR levels after regular exercise compared to a control group implying that suPAR rather reflects underlying harmful inflammatory responses associated with disease development.
可溶性尿激酶型纤溶酶原激活物受体(suPAR)是一种新型炎症标志物,与生活方式疾病和死亡风险相关。尚无研究采用随机对照设计来调查体力活动是否可降低 suPAR 水平。
2008 年,我们在挪威对巴基斯坦移民进行了一项随机对照试验,测定了该试验中参与者的血液样本中的 suPAR 和 C 反应蛋白(CRP)水平。该研究纳入了不活跃的男性,他们被随机分配到干预组(监督组锻炼)或对照组,并随访 5 个月。采用线性回归模型,并根据年龄、基线时的不活动水平以及 CRP 水平的平均差异进行调整。
总体而言,干预组和对照组分别纳入 80 名和 53 名参与者。肥胖和吸烟与基线时较高的 suPAR 水平相关。干预组的基线时 suPAR 水平为 2.65(95%CI=2.48-2.78)ng/mL,而在测试后为 2.80(95%CI=2.65-2.95)ng/mL,因此干预后 suPAR 水平显著升高(p=0.02)。在对照组中,suPAR 水平从基线时的 2.93(95%CI=2.68-3.16)ng/mL 显著升高至测试后的 3.09(95%CI=2.81-3.38)ng/mL(p=0.04)。比较干预组与对照组从基线到测试后的 suPAR 水平变化,在未调整模型中未发现显著变化(β=-0.002,95%CI=-0.219-0.215)。CRP 水平也得到了类似的结果。
与对照组相比,经常运动后 suPAR 水平没有变化,这表明 suPAR 更多地反映了与疾病发展相关的潜在有害炎症反应。